Page last updated: 2024-09-03

substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-

substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with substance p, arg(1)-pro(2)-trp(7,9)-leu(11)- in 1 studies

Compound Research Comparison

Studies
(substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)
Trials
(substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)
Recent Studies (post-2010)
(substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)
Studies
(substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-)
Trials
(substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-)
Recent Studies (post-2010) (substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-)
20012200

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rozengurt, E; Woll, PJ1

Other Studies

1 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-

ArticleYear
A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
    Cancer research, 1990, Jul-01, Volume: 50, Issue:13

    Topics: Animals; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; Cells, Cultured; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Peptide Fragments; Peptides; Recombinant Proteins; Substance P; Tumor Cells, Cultured; Vasopressins

1990